Your browser doesn't support javascript.
loading
Development of Philadelphia chromosome-negative acute myeloid leukemia with IDH2 and NPM1 mutations in a patient with chronic myeloid leukemia who showed a major molecular response to tyrosine kinase inhibitor therapy.
Nakamura, Fumi; Arai, Honoka; Nannya, Yasuhito; Ichikawa, Motoshi; Furuichi, Shiho; Nagasawa, Fusako; Takahashi, Wataru; Handa, Tomoyuki; Nakamura, Yuko; Tanaka, Hiroko; Nakamura, Yuka; Sasaki, Ko; Miyano, Satoru; Ogawa, Seishi; Mitani, Kinuko.
Affiliation
  • Nakamura F; Department of Hematology and Oncology, Dokkyo Medical University, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi, 321-0293, Japan.
  • Arai H; Department of Hematology and Oncology, Dokkyo Medical University, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi, 321-0293, Japan.
  • Nannya Y; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Ichikawa M; Department of Hematology and Oncology, Dokkyo Medical University, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi, 321-0293, Japan.
  • Furuichi S; Department of Hematology and Oncology, Dokkyo Medical University, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi, 321-0293, Japan.
  • Nagasawa F; Department of Hematology and Oncology, Dokkyo Medical University, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi, 321-0293, Japan.
  • Takahashi W; Department of Hematology and Oncology, Dokkyo Medical University, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi, 321-0293, Japan.
  • Handa T; Department of Hematology and Oncology, Dokkyo Medical University, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi, 321-0293, Japan.
  • Nakamura Y; Department of Hematology and Oncology, Dokkyo Medical University, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi, 321-0293, Japan.
  • Tanaka H; Laboratory of DNA Information Analysis, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Nakamura Y; Department of Hematology and Oncology, Dokkyo Medical University, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi, 321-0293, Japan.
  • Sasaki K; Department of Hematology and Oncology, Dokkyo Medical University, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi, 321-0293, Japan.
  • Miyano S; Laboratory of DNA Information Analysis, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Ogawa S; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Mitani K; Department of Hematology and Oncology, Dokkyo Medical University, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi, 321-0293, Japan. kinukom-tky@umin.ac.jp.
Int J Hematol ; 113(6): 936-940, 2021 Jun.
Article in En | MEDLINE | ID: mdl-33400143
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinolines / Nuclear Proteins / Protein Kinase Inhibitors / Dasatinib / Isocitrate Dehydrogenase / Aniline Compounds / Mutation / Neoplasm Proteins / Nitriles Type of study: Prognostic_studies Limits: Humans / Male / Middle aged Language: En Journal: Int J Hematol Journal subject: HEMATOLOGIA Year: 2021 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinolines / Nuclear Proteins / Protein Kinase Inhibitors / Dasatinib / Isocitrate Dehydrogenase / Aniline Compounds / Mutation / Neoplasm Proteins / Nitriles Type of study: Prognostic_studies Limits: Humans / Male / Middle aged Language: En Journal: Int J Hematol Journal subject: HEMATOLOGIA Year: 2021 Type: Article Affiliation country: Japan